The Food and Drug Administration (FDA) has expanded its approval of a ketamine-derived nasal spray, Spravato (esketamine), as a standalone therapy for adults with treatment-resistant depression.

David Paul Morris / Bloomberg via Getty Images Apple was one of the few mega-cap tech stocks rising on Monday amid a rout that sank shares of cloud hyperscalers, AI chip makers and nuclear power ...

The FDA’s latest approval of the nasal spray Spravato (esketamine) CIII marks a major shift in how major depressive disorder is managed, allowing people who have tried at least two oral ...

Apple's next iPhone will launch early in 2025, and the community is eagerly awaiting the iPhone SE, which promises to be one of the most disruptive iPhones in recent years. When will they be able ...

A Y2K-era phenomenon most famous for his MTV prank show and surreal brand of comedy, Green pioneered ideas that thrive today. A Y2K-era phenomenon most famous for his MTV prank show and surreal ...

The company even revealed its own take on Apple’s second-gen Photographic Styles, which lets our fellow green-bubbled folks apply advanced filters to their shots and control their tones.

Johnson & Johnson has announced the FDA’s approval of a first-of-its-kind, esketamine nasal spray called Spravato for the standalone treatment of major depressive disorder (MDD), PTSD ...

Jan. 21 (UPI) --The Food and Drug Administration has approved the first-ever stand-alone nasal spray to treat drug-resistant depression. Johnson & Johnson's Spravato has been approved to treat a ...

NEW YORK (PIX11) – A nose spray has been approved by the U.S. Food and Drug Administration to help treat depression, Johnson & Johnson announced on Tuesday. Spravato is a first-of-its-kind ...

Green Day's long-awaited South African debut on Jan. 19 was anything but ordinary. By Jessica Lynch Green Day delivered a politically charged performance during their Jan. 19 concert at ...